Phenylketonuria: Difference between revisions
Jump to navigation
Jump to search
imported>Chris Day No edit summary |
imported>Chris Day No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Phenylketouria''' (PKU) is a metabolic disease due to the loss of an enzyme [[phenylalanine hydroxylase]] (PAH) that is required to metabolise the amino acid [[phenylalanine]] to [[tyrosine]]. The impact of this deficiency can be severe causing mental retardation and organ damage. It is commonly known since it is one of several genetic diseases that babies are screened for at birth. Neonatal screening is critical since changes in the diet, limiting the intake of phenylalanine, can reduce the severity of the symptoms. | '''Phenylketouria''' (PKU) is a metabolic disease due to the loss of an enzyme [[phenylalanine hydroxylase]] (PAH) that is required to metabolise the amino acid [[phenylalanine]] to [[tyrosine]]. The impact of this deficiency can be severe causing mental retardation and organ damage. It is commonly known since it is one of several genetic diseases that babies are screened for at birth. Neonatal screening is critical since changes in the diet, limiting the intake of phenylalanine and supplemented with tyrosine, can reduce the severity of the symptoms allowing those with the diesease to lead relatively normal lives. | ||
Revision as of 15:46, 25 September 2008
Phenylketouria (PKU) is a metabolic disease due to the loss of an enzyme phenylalanine hydroxylase (PAH) that is required to metabolise the amino acid phenylalanine to tyrosine. The impact of this deficiency can be severe causing mental retardation and organ damage. It is commonly known since it is one of several genetic diseases that babies are screened for at birth. Neonatal screening is critical since changes in the diet, limiting the intake of phenylalanine and supplemented with tyrosine, can reduce the severity of the symptoms allowing those with the diesease to lead relatively normal lives.